La bourse est fermée
  • CAC 40

    5 598,18
    +31,39 (+0,56 %)
     
  • Euro Stoxx 50

    3 527,79
    +16,85 (+0,48 %)
     
  • Dow Jones

    29 910,37
    +37,90 (+0,13 %)
     
  • EUR/USD

    1,1970
    +0,0057 (+0,48 %)
     
  • Gold future

    1 781,90
    -23,60 (-1,31 %)
     
  • BTC-EUR

    14 201,59
    -76,78 (-0,54 %)
     
  • CMC Crypto 200

    333,27
    -4,23 (-1,25 %)
     
  • Pétrole WTI

    45,53
    -0,18 (-0,39 %)
     
  • DAX

    13 335,68
    +49,11 (+0,37 %)
     
  • FTSE 100

    6 367,58
    +4,65 (+0,07 %)
     
  • Nasdaq

    12 205,85
    +111,44 (+0,92 %)
     
  • S&P 500

    3 638,35
    +8,70 (+0,24 %)
     
  • Nikkei 225

    26 644,71
    +107,40 (+0,40 %)
     
  • HANG SENG

    26 894,68
    +75,23 (+0,28 %)
     
  • GBP/USD

    1,3314
    -0,0042 (-0,32 %)
     

US Asthma Spacers Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Product and Distribution Channel

ReportLinker
·2 min de lecture

The US asthma spacers market was valued at US$ 472. 92 million in 2019 and is projected to reach US$ 702. 27 million by 2027; it is expected to grow at a CAGR of 5. 3% during 2020-2027. The market growth is mainly attributed to factors such as increasing prevalence of respiratory conditions and growing awareness regarding benefits conferred by spacers.

New York, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "US Asthma Spacers Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Product and Distribution Channel" - https://www.reportlinker.com/p05978940/?utm_source=GNW
However, increased risk of adverse effects due to unlicensed prescriptions restrains the growth of the market.

Asthma spacers are tube-like devices that are attached to inhalers for better administration of doses. Generally, spacers help administer the medication directly to lungs, thereby reducing the chances of side effects that may occur when the drug comes in contact with mouth and throat.

The COVID-19 pandemic has affected on the US asthma spacers market.It has disrupted the supply chain operations in the country.

However, the healthcare authorities and government organizations in the US are focusing on spreading awareness about COVID-19 among asthmatic patients as they are highly vulnerable to other lung infections. Such awareness programs are likely to have positive impact on the adoption of asthma spacers due to precautionary measures, which will eventually drive the market up to certain extent.

Based on product, the asthma spacers market is segmented into aerochamber, optichamber, volumatic, and inspirease.The aerochamber segment held the largest share of the market in 2019; it is further is anticipated to register the highest CAGR in the market during the forecast period.

Based on distribution channel, the asthma spacers market is segmented into retail pharmacy, hospital pharmacy, and E-commerce. The retail pharmacy segment held the largest share of the market in 2019; however, E-commerce segment estimated to register the highest CAGR in the market during the forecast period.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Asthma and Allergy Foundation of America are among the major primary and secondary sources referred to while preparing the US asthma spacers market report.
Read the full report: https://www.reportlinker.com/p05978940/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001